| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/24/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 20k | $2.80 | $56k | | 06/24/2022 |
| 06/21/2022 | Graphite Bio, Inc. | | Grant | Stock Option (right to buy) | 20k | $2.54 | $50.8k | | 06/21/2022 |
| 06/29/2021 | Graphite Bio, Inc. | | Conversion | Series B Preferred Stock | 19.8k | $0.00 | $0 | | 01/13/2021 |
| 06/29/2021 | Graphite Bio, Inc. | | Conversion | Common Stock | 8.1k | $0.00 | $0 | | 01/13/2021 |
| 06/18/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.27 | $114.1k | | 06/18/2021 |
| 03/17/2021 | Graphite Bio, Inc. | | Grant | Stock Option (right to buy) | 18.7k | $0.00 | $0 | | 01/13/2021 |
| 03/11/2021 | Graphite Bio, Inc. | | Grant | Series B Preferred Stock | 19.8k | $5.06 | $100k | | 01/13/2021 |
| 01/13/2021 | Graphite Bio, Inc. | | Grant | Stock Option (right to buy) | 74.8k | $0.00 | $0 | | 01/13/2021 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 22k | $52.52 | $1.2M | | 12/17/2020 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 45.4k | $53.69 | $2.4M | | 12/17/2020 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Sale | Common Stock | 21.3k | $54.33 | $1.2M | | 12/17/2020 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 31.8k | $18.00 | $571.8k | | 12/17/2020 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 19k | $14.35 | $272.6k | | 12/17/2020 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 19k | $25.98 | $493.6k | | 12/17/2020 |
| 12/17/2020 | Intellia Therapeutics, Inc. | NTLA | Exercise | Stock Option (right to buy) | 19k | $15.78 | $299.8k | | 12/17/2020 |
| 06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.58 | $119k | | 06/26/2020 |
| 06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.58 | $102.7k | | 06/26/2020 |
| 06/18/2020 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 19k | $20.72 | $393.7k | | 06/18/2020 |
| 06/13/2019 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $24.68 | $370.2k | | 06/13/2019 |
| 06/12/2019 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $4.46 | $70k | | 06/12/2019 |
| 05/21/2019 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 19k | $15.78 | $299.8k | | 05/21/2019 |
| 04/23/2019 | OncoMed Pharmaceuticals Inc | OMED | Other | Common Stock | 80.5k | $0.00 | $0 | | 04/23/2019 |
| 06/22/2018 | OncoMed Pharmaceuticals Inc | OMED | Grant | Stock Option (Right to Buy) | 15k | $2.55 | $38.2k | | 06/22/2018 |
| 06/19/2018 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 13.6k | $7.92 | $107.3k | | 06/19/2018 |
| 06/14/2018 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $21.64 | $324.6k | | 06/14/2018 |
| 05/17/2018 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 19k | $25.98 | $493.6k | | 05/17/2018 |
| 02/26/2018 | OncoMed Pharmaceuticals Inc | OMED | Grant | Common Stock | 70.5k | $0.00 | $0 | | 02/26/2018 |
| 02/26/2018 | OncoMed Pharmaceuticals Inc | OMED | Grant | Stock Option (Right to Buy) | 120k | $2.29 | $274.8k | | 02/26/2018 |
| 06/05/2017 | OncoMed Pharmaceuticals Inc | OMED | Purchase | Common Stock | 10k | $3.46 | $34.6k | | 06/05/2017 |
| 06/01/2017 | OncoMed Pharmaceuticals Inc | OMED | Grant | Stock Option (Right to Buy) | 15k | $3.30 | $49.5k | | 06/01/2017 |
| 06/01/2017 | Intellia Therapeutics, Inc. | NTLA | Grant | Common Stock | 5k | $11.99 | $59.9k | | 06/01/2017 |
| 05/18/2017 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 19k | $14.35 | $272.6k | | 05/18/2017 |
| 02/01/2017 | Jounce Therapeutics, Inc. | JNCE | Purchase | Common Stock | 5k | $16.00 | $80k | | 02/01/2017 |
| 06/15/2016 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $13.70 | $205.5k | | 06/15/2016 |
| 05/05/2016 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 31.8k | $18.00 | $571.8k | | 05/05/2016 |
|